Significant disparities exist in US and European tumour care models. Generally , the US system relies more on cutting-edge innovation and bespoke interventions , sometimes at a greater cost . In https://maevnae265335.blog5.net/92067691/american-vs-continental-malignancy-management-a-comparative-review